samedan logo
 
 
 
spacer
home > ebr > summer 2003 > editor's letter
PUBLICATIONS
European Biopharmaceutical Review

Editor's Letter

The Summer 2003 issue of EBR makes its entrance in time for the Annual BIO Convention in Washington this year - a city that has been the focus of much attention on the world stage in recent months. Politics aside, wars do not help settle global stock markets, even when relatively short in duration it seems. Thus the pain of closed stock markets continues as far as the global biotechnology industry is concerned. The more mature US market has been there, or somewhere close, before, as have certain countries in Europe. However, for the majority of European biotech companies the storm is far from over, as reflected in Ernst & Young's recently launched European Biotechnology Report 2003, reviewed in brief in this issue.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Senior Consultant at Technomark Consulting Services
spacer
Dr Helen Abbott
spacer
spacer
spacer
Amy Curtis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership

Gerresheimers first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging First joint project of Gerresheimer and Midas Pharma: Development and marketing of new autoinjector One-stop-shop for biotech and pharma customers Duesseldorf, November 08, 2021 Gerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a strategic partnership. The joint project comprises the development and marketing of the new generation autoinjector.
More info >>

White Papers

Trial Timelines

Thomson Reuters

Save resources with accurate trial length projections. How analytics based on curated content can deliver insight for clinical strategies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement